An Exploratory Study of the Effect of Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/053/31/07

Funding

  • Bristol Myers Squibb Company: $4,200.00